TY - STD TI - DiNicolantonio JJ, Lucan SC, O’Keefe JH. The evidence for saturated fat and for sugar related to coronary heart disease. Prog Cardiovasc Dis. 2015. ID - ref1 ER - TY - JOUR AU - Wu, T. AU - Sun, Q. F. AU - Yang, P. S. AU - Feng, W. AU - Liu, X. L. PY - 2010 DA - 2010// TI - [Levels of inflammation cytokines in patients with coronary heart disease and periodontal disease] JO - Zhonghua Kou Qiang Yi Xue Za Zhi VL - 45 ID - Wu2010 ER - TY - JOUR AU - Ma, Y. AU - Ockene, I. S. AU - Rosal, M. C. AU - Merriam, P. A. AU - Ockene, J. K. AU - Gandhi, P. J. PY - 2010 DA - 2010// TI - Randomized trial of a pharmacist-delivered intervention for improving lipid-lowering medication adherence among patients with coronary heart disease JO - Cholesterol VL - 2010 UR - https://doi.org/10.1155/2010/383281 DO - 10.1155/2010/383281 ID - Ma2010 ER - TY - JOUR AU - Rosen, V. M. AU - Taylor, D. C. AU - Parekh, H. AU - Pandya, A. AU - Thompson, D. AU - Kuznik, A. AU - Waters, D. D. AU - Drummond, M. AU - Weinstein, M. C. PY - 2010 DA - 2010// TI - Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US JO - Pharmacoeconomics VL - 28 UR - https://doi.org/10.2165/11531440-000000000-00000 DO - 10.2165/11531440-000000000-00000 ID - Rosen2010 ER - TY - JOUR AU - Bittner, V. AU - Deng, L. AU - Rosenson, R. S. AU - Taylor, B. AU - Glasser, S. P. AU - Kent, S. T. AU - Farkouh, M. E. AU - Muntner, P. PY - 2015 DA - 2015// TI - Trends in the use of nonstatin lipid-lowering therapy among patients with coronary heart disease: a retrospective cohort study in the medicare population 2007 to 2011 JO - J Am Coll Cardiol VL - 66 UR - https://doi.org/10.1016/j.jacc.2015.08.042 DO - 10.1016/j.jacc.2015.08.042 ID - Bittner2015 ER - TY - JOUR AU - Dargel, R. PY - 1989 DA - 1989// TI - The lipid infiltration theory of atherosclerosis JO - Z Med Lab Diagn VL - 30 ID - Dargel1989 ER - TY - JOUR AU - Graham, I. AU - Cooney, M. T. AU - Bradley, D. AU - Dudina, A. AU - Reiner, Z. PY - 2012 DA - 2012// TI - Dyslipidemias in the prevention of cardiovascular disease: risks and causality JO - Curr Cardiol Rep VL - 14 UR - https://doi.org/10.1007/s11886-012-0313-7 DO - 10.1007/s11886-012-0313-7 ID - Graham2012 ER - TY - JOUR AU - Barter, P. PY - 2004 DA - 2004// TI - HDL: a recipe for longevity JO - Atheroscler Suppl VL - 5 UR - https://doi.org/10.1016/j.atherosclerosissup.2004.03.003 DO - 10.1016/j.atherosclerosissup.2004.03.003 ID - Barter2004 ER - TY - JOUR AU - Mulay, V. AU - Wood, P. AU - Rentero, C. AU - Enrich, C. AU - Grewal, T. PY - 2012 DA - 2012// TI - Signal transduction pathways provide opportunities to enhance HDL and apoAI-dependent reverse cholesterol transport JO - Curr Pharm Biotechnol VL - 13 UR - https://doi.org/10.2174/138920112799095356 DO - 10.2174/138920112799095356 ID - Mulay2012 ER - TY - JOUR AU - Tuunanen, H. AU - Ukkonen, H. AU - Knuuti, J. PY - 2008 DA - 2008// TI - Myocardial fatty acid metabolism and cardiac performance in heart failure JO - Curr Cardiol Rep VL - 10 UR - https://doi.org/10.1007/s11886-008-0024-2 DO - 10.1007/s11886-008-0024-2 ID - Tuunanen2008 ER - TY - JOUR AU - Cook, G. A. AU - Edwards, T. L. AU - Jansen, M. S. AU - Bahouth, S. W. AU - Wilcox, H. G. AU - Park, E. A. PY - 2001 DA - 2001// TI - Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart JO - J Mol Cell Cardiol VL - 33 UR - https://doi.org/10.1006/jmcc.2000.1304 DO - 10.1006/jmcc.2000.1304 ID - Cook2001 ER - TY - JOUR AU - Mengi, S. A. AU - Dhalla, N. S. PY - 2004 DA - 2004// TI - Carnitine palmitoyltransferase-I, a new target for the treatment of heart failure: perspectives on a shift in myocardial metabolism as a therapeutic intervention JO - Am J Cardiovasc Drugs VL - 4 UR - https://doi.org/10.2165/00129784-200404040-00001 DO - 10.2165/00129784-200404040-00001 ID - Mengi2004 ER - TY - JOUR AU - Wang, Y. AU - Li, C. AU - Wang, Q. AU - Shi, T. AU - Wang, J. AU - Chen, H. AU - Wu, Y. AU - Han, J. AU - Guo, S. AU - Wang, W. PY - 2015 DA - 2015// TI - Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway JO - BMC Complement Altern Med VL - 15 UR - https://doi.org/10.1186/s12906-015-0548-0 DO - 10.1186/s12906-015-0548-0 ID - Wang2015 ER - TY - JOUR AU - Kantor, P. F. AU - Lucien, A. AU - Kozak, R. AU - Lopaschuk, G. D. PY - 2000 DA - 2000// TI - The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase JO - Circ Res VL - 86 UR - https://doi.org/10.1161/01.RES.86.5.580 DO - 10.1161/01.RES.86.5.580 ID - Kantor2000 ER - TY - STD TI - Marchant DJ, Boyd JH, Lin DC, Granville DJ, Garmaroudi FS, McManus BM. Inflammation in myocardial diseases. Circ Res. 2012;110(1):126-44. ID - ref15 ER - TY - JOUR AU - Chandrasekharan, N. V. AU - Simmons, D. L. PY - 2004 DA - 2004// TI - The cyclooxygenases JO - Genome Biol VL - 5 UR - https://doi.org/10.1186/gb-2004-5-9-241 DO - 10.1186/gb-2004-5-9-241 ID - Chandrasekharan2004 ER - TY - JOUR AU - Surh, Y. J. AU - Chun, K. S. AU - Cha, H. H. AU - Han, S. S. AU - Keum, Y. S. AU - Park, K. K. AU - Lee, S. S. PY - 2001 DA - 2001// TI - Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation JO - Mutat Res VL - 480–481 UR - https://doi.org/10.1016/S0027-5107(01)00183-X DO - 10.1016/S0027-5107(01)00183-X ID - Surh2001 ER - TY - JOUR AU - LaPointe, M. C. AU - Mendez, M. AU - Leung, A. AU - Tao, Z. Y. AU - Yang, X. P. PY - 2004 DA - 2004// TI - Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse JO - Am J Physiol-Heart C VL - 286 UR - https://doi.org/10.1152/ajpheart.00136.2003 DO - 10.1152/ajpheart.00136.2003 ID - LaPointe2004 ER - TY - JOUR AU - Ray, W. A. AU - Stein, C. M. AU - Daugherty, J. R. AU - Hall, K. AU - Arbogast, P. G. AU - Griffin, M. R. PY - 2002 DA - 2002// TI - COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11131-7 DO - 10.1016/S0140-6736(02)11131-7 ID - Ray2002 ER - TY - JOUR AU - Robinson, E. AU - Grieve, D. J. PY - 2009 DA - 2009// TI - Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease JO - Pharmacol Ther VL - 122 UR - https://doi.org/10.1016/j.pharmthera.2009.03.003 DO - 10.1016/j.pharmthera.2009.03.003 ID - Robinson2009 ER - TY - JOUR AU - Nissen, S. E. AU - Wolski, K. PY - 2007 DA - 2007// TI - Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa072761 DO - 10.1056/NEJMoa072761 ID - Nissen2007 ER - TY - STD TI - Rakhshandehroo M, Knoch B, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010;2010. ID - ref22 ER - TY - JOUR AU - Bocher, V. AU - Chinetti, G. AU - Fruchart, J. C. AU - Staels, B. PY - 2002 DA - 2002// TI - [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control] JO - J Soc Biol VL - 196 ID - Bocher2002 ER - TY - JOUR AU - Wilson, J. L. AU - Duan, R. AU - El-Marakby, A. AU - Alhashim, A. AU - Lee, D. L. PY - 2012 DA - 2012// TI - Peroxisome Proliferator Activated Receptor-alpha Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice JO - PPAR Res VL - 2012 UR - https://doi.org/10.1155/2012/645969 DO - 10.1155/2012/645969 ID - Wilson2012 ER - TY - JOUR AU - Wang, Y. AU - Li, C. AU - Liu, Z. AU - Shi, T. AU - Wang, Q. AU - Li, D. AU - Wu, Y. AU - Han, J. AU - Guo, S. AU - Tang, B. PY - 2014 DA - 2014// TI - DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 JO - BMC Complement Altern Med VL - 14 UR - https://doi.org/10.1186/1472-6882-14-67 DO - 10.1186/1472-6882-14-67 ID - Wang2014 ER - TY - JOUR AU - Chen, J. AU - Wang, F. AU - Lee, F. S. AU - Wang, X. AU - Xie, M. PY - 2006 DA - 2006// TI - Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis JO - Talanta VL - 69 UR - https://doi.org/10.1016/j.talanta.2005.09.041 DO - 10.1016/j.talanta.2005.09.041 ID - Chen2006 ER - TY - JOUR AU - Wan, J. B. AU - Lai, C. M. AU - Li, S. P. AU - Lee, M. Y. AU - Kong, L. Y. AU - Wang, Y. T. PY - 2006 DA - 2006// TI - Simultaneous determination of nine saponins from Panax notoginseng using HPLC and pressurized liquid extraction JO - J Pharm Biomed Anal VL - 41 UR - https://doi.org/10.1016/j.jpba.2005.10.023 DO - 10.1016/j.jpba.2005.10.023 ID - Wan2006 ER - TY - JOUR PY - 2010 DA - 2010// TI - China pharmaceutical standards for formulations and the drug prescription of the ministry of health of the People’s Republic JO - Chin Med Sci Technol Press VL - 1 ID - ref28 ER - TY - JOUR AU - Chen, S. AU - Liu, J. AU - Liu, X. AU - Fu, Y. AU - Zhang, M. AU - Lin, Q. AU - Zhu, J. AU - Mai, L. AU - Shan, Z. AU - Yu, X. PY - 2011 DA - 2011// TI - Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes JO - J Ethnopharmacol VL - 137 UR - https://doi.org/10.1016/j.jep.2011.05.011 DO - 10.1016/j.jep.2011.05.011 ID - Chen2011 ER - TY - JOUR AU - Tu, E. Y. AU - Zhou, Y. G. AU - Wang, Z. H. AU - Liang, Q. S. AU - Yang, G. T. PY - 2009 DA - 2009// TI - Effects of tanshinone II A on the myocardial hypertrophy signal transduction system protein kinase B in rats JO - Chin J Integr Med VL - 15 UR - https://doi.org/10.1007/s11655-009-0365-8 DO - 10.1007/s11655-009-0365-8 ID - Tu2009 ER - TY - JOUR AU - Wang, Y. AU - Li, C. AU - Ouyang, Y. L. AU - Chuo, W. J. AU - Yu, J. D. AU - Han, J. AU - Chen, J. X. AU - Wang, W. PY - 2012 DA - 2012// TI - The study on therapy effect of Danqi pill to renin-angiotensin-aldosterone system (RAAS) and lipid metabolism disorder in coronary heart disease JO - Afr J Pharm Pharmaco VL - 6 UR - https://doi.org/10.5897/AJPP12.963 DO - 10.5897/AJPP12.963 ID - Wang2012 ER - TY - STD TI - Wang Y, Li C, Wang QY, Shi TJ, Wang J, Chen H, Wu Y, Han J, Guo SZ, Wang YY, et al. Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway. Bmc Complem Altern M. 2015;15. ID - ref32 ER - TY - JOUR AU - Shang, Q. H. AU - Liu, Z. L. AU - Chen, K. J. AU - Xu, H. AU - Liu, J. P. PY - 2012 DA - 2012// TI - A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia JO - Evid-Based Compl Alt VL - 2012 ID - Shang2012 ER - TY - JOUR AU - Gao, Z. Y. AU - Xu, H. AU - Shi, D. Z. AU - Wen, C. AU - Liu, B. Y. PY - 2012 DA - 2012// TI - Analysis on outcome of 5284 patients with coronary artery disease: The role of integrative medicine JO - J Ethnopharmacol VL - 141 UR - https://doi.org/10.1016/j.jep.2011.08.071 DO - 10.1016/j.jep.2011.08.071 ID - Gao2012 ER - TY - JOUR AU - Rana, J. S. AU - Visser, M. E. AU - Arsenault, B. J. AU - Despres, J. P. AU - Stroes, E. S. AU - Kastelein, J. J. AU - Wareham, N. J. AU - Boekholdt, S. M. AU - Khaw, K. T. PY - 2010 DA - 2010// TI - Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study JO - Int J Cardiol VL - 143 UR - https://doi.org/10.1016/j.ijcard.2009.03.123 DO - 10.1016/j.ijcard.2009.03.123 ID - Rana2010 ER - TY - JOUR AU - Majeed, F. AU - Miller, M. PY - 2008 DA - 2008// TI - Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assessment JO - Curr Opin Endocrinol Diabetes Obes VL - 15 UR - https://doi.org/10.1097/MED.0b013e3282f79b0b DO - 10.1097/MED.0b013e3282f79b0b ID - Majeed2008 ER - TY - JOUR AU - Greene, D. J. AU - Skeggs, J. W. AU - Morton, R. E. PY - 2001 DA - 2001// TI - Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI) JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M008725200 DO - 10.1074/jbc.M008725200 ID - Greene2001 ER - TY - JOUR AU - Skeggs, J. W. AU - Morton, R. E. PY - 2002 DA - 2002// TI - LDL and HDL enriched in triglyceride promote abnormal cholesterol transport JO - J Lipid Res VL - 43 ID - Skeggs2002 ER - TY - JOUR AU - Carey, V. J. AU - Bishop, L. AU - Laranjo, N. AU - Harshfield, B. J. AU - Kwiat, C. AU - Sacks, F. M. PY - 2010 DA - 2010// TI - Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control JO - Am J Cardiol VL - 106 UR - https://doi.org/10.1016/j.amjcard.2010.05.002 DO - 10.1016/j.amjcard.2010.05.002 ID - Carey2010 ER - TY - JOUR AU - Cui, Y. AU - Watson, D. J. AU - Girman, C. J. AU - Shapiro, D. R. AU - Gotto, A. M. AU - Hiserote, P. AU - Clearfield, M. B. PY - 2009 DA - 2009// TI - Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study) JO - Am J Cardiol VL - 104 UR - https://doi.org/10.1016/j.amjcard.2009.05.020 DO - 10.1016/j.amjcard.2009.05.020 ID - Cui2009 ER - TY - JOUR AU - Ibanez, B. AU - Vilahur, G. AU - Cimmino, G. AU - Speidl, W. S. AU - Pinero, A. AU - Choi, B. G. AU - Zafar, M. U. AU - Santos-Gallego, C. G. AU - Krause, B. AU - Badimon, L. PY - 2008 DA - 2008// TI - Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2007.09.071 DO - 10.1016/j.jacc.2007.09.071 ID - Ibanez2008 ER - TY - JOUR AU - Nicholls, S. J. AU - Gordon, A. AU - Johannson, J. AU - Ballantyne, C. M. AU - Barter, P. J. AU - Brewer, H. B. AU - Kastelein, J. J. P. AU - Wong, N. C. AU - Borgman, M. R. N. AU - Nissen, S. E. PY - 2012 DA - 2012// TI - ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies JO - Cardiovasc Drug Ther VL - 26 UR - https://doi.org/10.1007/s10557-012-6373-5 DO - 10.1007/s10557-012-6373-5 ID - Nicholls2012 ER - TY - JOUR AU - Cockerill, G. W. AU - Rye, K. A. AU - Gamble, J. R. AU - Vadas, M. A. AU - Barter, P. J. PY - 1995 DA - 1995// TI - High-density-lipoproteins inhibit cytokine-induced expression of endothelial-cell adhesion molecules JO - Arterioscl Throm Vas VL - 15 UR - https://doi.org/10.1161/01.ATV.15.11.1987 DO - 10.1161/01.ATV.15.11.1987 ID - Cockerill1995 ER - TY - JOUR AU - Berk, P. D. PY - 2008 DA - 2008// TI - Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome JO - Hepatology VL - 48 UR - https://doi.org/10.1002/hep.22632 DO - 10.1002/hep.22632 ID - Berk2008 ER - TY - JOUR AU - Luiken, J. J. F. P. AU - Koonen, D. P. Y. AU - Willems, J. AU - Zorzano, A. AU - Becker, C. AU - Fischer, Y. AU - Tandon, N. N. AU - Vusse, G. J. AU - Bonen, A. AU - Glatz, J. F. C. PY - 2002 DA - 2002// TI - Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36 JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.10.3113 DO - 10.2337/diabetes.51.10.3113 ID - Luiken2002 ER - TY - JOUR AU - Tanaka, T. AU - Nakata, T. AU - Oka, T. AU - Ogawa, T. AU - Okamoto, F. AU - Kusaka, Y. AU - Sohmiya, K. AU - Shimamoto, K. AU - Itakura, K. PY - 2001 DA - 2001// TI - Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations JO - J Lipid Res VL - 42 ID - Tanaka2001 ER - TY - JOUR AU - Smith, B. K. AU - Jain, S. S. AU - Rimbaud, S. AU - Dam, A. AU - Quadrilatero, J. AU - Ventura-Clapier, R. AU - Bonen, A. AU - Holloway, G. P. PY - 2011 DA - 2011// TI - FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation JO - Biochem J VL - 437 UR - https://doi.org/10.1042/BJ20101861 DO - 10.1042/BJ20101861 ID - Smith2011 ER - TY - JOUR AU - He, J. H. AU - Lee, J. H. AU - Febbraio, M. AU - Xie, W. PY - 2011 DA - 2011// TI - The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease JO - Exp Biol Med VL - 236 UR - https://doi.org/10.1258/ebm.2011.011128 DO - 10.1258/ebm.2011.011128 ID - He2011 ER - TY - JOUR AU - Bruce, C. R. AU - Hoy, A. J. AU - Turner, N. AU - Watt, M. J. AU - Allen, T. L. AU - Carpenter, K. AU - Cooney, G. J. AU - Febbraio, M. A. AU - Kraegen, E. W. PY - 2009 DA - 2009// TI - Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance JO - Diabetes VL - 58 UR - https://doi.org/10.2337/db08-1078 DO - 10.2337/db08-1078 ID - Bruce2009 ER - TY - JOUR AU - Levick, S. P. AU - Loch, D. C. AU - Taylor, S. M. AU - Janicki, J. S. PY - 2007 DA - 2007// TI - Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation JO - J Immunol VL - 178 UR - https://doi.org/10.4049/jimmunol.178.2.641 DO - 10.4049/jimmunol.178.2.641 ID - Levick2007 ER - TY - JOUR AU - Pitt, B. AU - Pepine, C. AU - Willerson, J. T. PY - 2002 DA - 2002// TI - Cyclooxygenase-2 inhibition and cardiovascular events JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000025261.58465.62 DO - 10.1161/01.CIR.0000025261.58465.62 ID - Pitt2002 ER - TY - JOUR AU - Issemann, I. AU - Prince, R. A. AU - Tugwood, J. D. AU - Green, S. PY - 1993 DA - 1993// TI - The peroxisome proliferator-activated receptor retinoid-x receptor heterodimer is activated by fatty-acids and fibrate hypolipemic drugs JO - J Mol Endocrinol VL - 11 UR - https://doi.org/10.1677/jme.0.0110037 DO - 10.1677/jme.0.0110037 ID - Issemann1993 ER - TY - JOUR AU - Auwerx, J. AU - Schoonjans, K. AU - Fruchart, J. C. AU - Staels, B. PY - 1996 DA - 1996// TI - Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR JO - Atherosclerosis VL - 124 UR - https://doi.org/10.1016/0021-9150(96)05854-6 DO - 10.1016/0021-9150(96)05854-6 ID - Auwerx1996 ER - TY - JOUR AU - Schoonjans, K. AU - Staels, B. AU - Auwerx, J. PY - 1996 DA - 1996// TI - Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression JO - J Lipid Res VL - 37 ID - Schoonjans1996 ER - TY - JOUR AU - Fruchart, J. C. PY - 2009 DA - 2009// TI - Peroxisome proliferator-activated receptor-alpha (PPAR alpha): at the crossroads of obesity, diabetes and cardiovascular disease JO - Atherosclerosis VL - 205 UR - https://doi.org/10.1016/j.atherosclerosis.2009.03.008 DO - 10.1016/j.atherosclerosis.2009.03.008 ID - Fruchart2009 ER - TY - JOUR AU - Yue, T. L. AU - Bao, W. AU - Jucker, B. M. AU - Gu, J. L. AU - Romanic, A. M. AU - Brown, P. J. AU - Cui, J. Q. AU - Thudium, D. T. AU - Boyce, R. AU - Burns-Kurtis, C. L. PY - 2003 DA - 2003// TI - Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000093187.42015.6C DO - 10.1161/01.CIR.0000093187.42015.6C ID - Yue2003 ER - TY - JOUR AU - Shonde, A. AU - Bennett, A. AU - Hawkey, C. J. PY - 2007 DA - 2007// TI - Suppression of cyclooxygenase (COX)-2 and cellular proliferation in colonocytes by indornethacin: role of leukotriene (LT)B4, a (Ppar)alpha ligand JO - Gastroenterology VL - 132 ID - Shonde2007 ER -